*Hopp-Children’s Cancer Center at the NCT Heidelberg
†Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), and German Cancer Consortium (DKTK)
‡Department of Pediatric Oncology and Hematology, University Hospital Heidelberg, Heidelberg
§Institute of Human Genetics, University of Ulm and University Hospital of Ulm, Ulm
∥Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg
∥∥Institute of Neuropathology, Medical Faculty, Heinrich Heine University, and German Cancer Consortium (DKTK), Partner Site Essen/Düsseldorf, Düsseldorf
¶¶Institute of Pathology, Friedrich-Alexander-University Erlangen-Nürnberg, University Hospital Erlangen, Erlangen
##Department of Neuropathology, Sozialstiftung Bamberg, Bamberg
***Department of Neuropathology, Charité Universitätsmedizin Berlin, Berlin
†††Swabian Children’s Cancer Center, Children’s Hospital Augsburg and EU-RHAB Registry, Augsburg
‡‡‡Institute of Neuropathology, University Hospital Münster, Münster, Germany
¶Department of Pathology, Mayo Clinic, Rochester, MN
#Division of Neuropathology, UCSF Medical Center, San Francisco, CA
**Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX
††Department of Pathology, Memorial Regional Hospital, Hollywood, FL
‡‡Department of Human Pathology, Gunma University Graduate School of Medicine, Gunma
§§Department of Neurosurgery, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan
Conflicts of Interest and Source of Funding: Supported by IZKF Münster (Ha3/019/15) and the DKFZ-Heidelberg Center for Personalized Oncology (DKFZ-HIPO). The authors have disclosed that they have no significant relationships with, or financial interest in, any commercial companies pertaining to this article.
Correspondence: Martin Hasselblatt, MD, Institute of Neuropathology, Pottkamp 2, Münster 48149, Germany (e-mail: [email protected]).
